Guru Ownership Trend
Guru Analysis for Fennec Pharmaceuticals Inc. (FENC)
Fennec Pharmaceuticals Inc. (FENC), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 3 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $3.32 M.
Top institutional holders include Renaissance Technologies (RenTech) and Cliff Asness.
Institutional sentiment is currently Bullish. This is evidenced by a $2.79 M net inflow during the quarter.
Recent activity highlights Cliff Asness who increased their stake by 284.7%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for Fennec Pharmaceuticals Inc. (FENC)
Major holders include Renaissance Technologies (RenTech) ($1.44 M), Cliff Asness ($998,557), Steven Cohen ($606,375). According to the latest reported data, 3 tracked investment managers collectively hold approximately 283,496 shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $2.79 M, with 3 managers increasing positions and 0 managers reducing holdings.
No tracked managers reduced or fully exited their positions in FENC during the most recent reporting period.
Yes, 2 managers opened new positions in FENC, and 1 increased their existing holdings. The total reported buy value was $2.79 M.